Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
PUT
Biohaven
BHVN
$2.03B
| $718K | ﹤0.01% |
+30,000
| New | +$516K |
|
4227
HDFC Bank
HDB
$123B
| $717K | ﹤0.01% |
20,582
-203,382
| -91% | -$6.86M |
|
4228
PUT
Vanguard FTSE Europe ETF
VGK
$30.7B
| $716K | ﹤0.01% |
+11,600
| New | +$721K |
|
4229
Cenntro
CENN
$7.89M
| $714K | ﹤0.01% |
+4,115
| New | +$871K |
|
|
FONR
4230
DELISTED
Fonar
FONR
| $714K | ﹤0.01% |
41,745
-955
| -2% | -$15.9K |
|
4231
CALL
Viridian Therapeutics
VRDN
$2.09B
| $714K | ﹤0.01% |
+30,000
| New | +$769K |
|
|
OMIC
4232
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $714K | ﹤0.01% |
+28,657
| New | +$840K |
|
|
NFGC
4233
New Found Gold
NFGC
$522M
| $713K | ﹤0.01% |
143,618
+70,807
| +97% | +$338K |
|
4234
Cousins Properties
CUZ
$5.19B
| $711K | ﹤0.01% |
+31,190
| New | +$652K |
|
4235
CALL
BioCryst Pharmaceuticals
BCRX
$2.28B
| $710K | ﹤0.01% |
100,900
-138,400
| -58% | -$1.11M |
|
|
STKL
4236
DELISTED
SunOpta
STKL
| $710K | ﹤0.01% |
106,165
-719,422
| -87% | -$5.41M |
|
4237
iShares Russell 3000 ETF
IWV
$19.6B
| $710K | ﹤0.01% |
+2,789
| New | +$671K |
|
4238
Tucows
TCX
$172M
| $709K | ﹤0.01% |
25,567
+11,670
| +84% | +$301K |
|
4239
Unitil
UTL
$970M
| $708K | ﹤0.01% |
13,963
-50,392
| -78% | -$2.8M |
|
|
PCGU
4240
DELISTED
PG&E Corporation
PCGU
| $705K | ﹤0.01% |
+4,701
| New | +$693K |
|
4241
Celldex Therapeutics
CLDX
$2.99B
| $704K | ﹤0.01% |
+20,740
| New | +$699K |
|
|
HBI
4242
CALL
DELISTED
Hanesbrands
HBI
| $701K | ﹤0.01% |
154,300
+4,100
| +3% | +$18.7K |
|
4243
PUT
Viking Therapeutics
VKTX
$3.7B
| $697K | ﹤0.01% |
43,000
-188,000
| -81% | -$3.94M |
|
4244
CALL
Prothena Corp
PRTA
$425M
| $696K | ﹤0.01% |
+10,200
| New | +$658K |
|
|
LSEA
4245
DELISTED
Landsea Homes
LSEA
| $695K | ﹤0.01% |
74,393
+4,934
| +7% | +$34.5K |
|
4246
Mistras Group
MG
$484M
| $693K | ﹤0.01% |
89,825
-260,325
| -74% | -$1.94M |
|
4247
CALL
Ultragenyx Pharmaceutical
RARE
$2.45B
| $692K | ﹤0.01% |
+15,000
| New | +$696K |
|
4248
PUT
Mercury Systems
MRCY
$5.83B
| $692K | ﹤0.01% |
+20,000
| New | +$854K |
|
4249
Prudential
PUK
$37.6B
| $691K | ﹤0.01% |
24,413
-14,045
| -37% | -$402K |
|
4250
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
| $690K | ﹤0.01% |
10,600
-92,000
| -90% | -$5.6M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.